Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 19, n. 1, 2018. DOI: 10.7175/fe.v19i1.1354. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1354. Acesso em: 29 oct. 2025.